Publications:

1.

Gibson H, Munns S, Freytag S, Barton K, Veenstra J, Bettahi I,

Bissonette J, Wei WZ. Immunotherapeutic intervention with oncolytic
adenovirus in mouse mammary tumors.
Oncoimmunology. 2015 Feb; 3;4(1): e984523.

2.

Bettahi I, Wang F, Sun H, Gao N and Yu FS. Genome-wide

transcriptional analysis of differentially expressed genes in diabetic,
healing corneal epithelial cells: hyperglycemia-suppressed TGF3
expression contributes to the delay of epithelial wound healing in
diabetic Corneas.
Diabetes. 2014 Feb; 63(2):715-27.

3.

Zhang X, Dervillez X, Chentouffi AA, Badakshan T, Bettahi I,

Benmohamed L. Targeting Genital Tract Mucosa with a
Lipopeptide/Recombinant Adenovirus Prime/Boost Vaccine Induces
Potent and Long-Lasting CD8+T Cell Immunity against Herpes:
Important of MYD88. J.Immunol. 2012 Nov1; 189(9):4496-509.

4.

Cheng C, Jain P, Bettahi I, Pal S, Tifrea D, de la Maza LM. A TLR2

agonist is a more effective adjuvant for a Chlamydia major outer
membrane protein vaccine than ligands to other TLR and NOD
receptors. Vaccine. 2011 Sep 2; 29(38):6641-9.

5.

Cheng C, Pal S, Bettahi I, Oxford KL, Barry PA, de la Maza LM.

Immunogenicity of vaccine formulated with the Chlamydia trachomatis
serovar F, native major outer membrane protein in a nonhuman
primate model. Vaccine. 2011 Mar 2; 18:3456-64.

6.

Renaudet O, Dasgupta G, Bettahi I, Shi A, Nesburn AB, Dumy P,

Benmohamed L. Linear and branched glyolico-lipopeptide vaccines
follow distinct cross-presentation generate different magnitudes of
antitumor immunity. PloS One 2010 Jun 21;5(6):e11216.

7.

Chentouffi AA, Dasgupta G, Nesburn AB, Bettahi I, Binder NR,

Choudhury ZS Chamberlain WD, Wechsler SL, BenMohamed L.
Nasolacrimal duct closure modulated ocular mucosal and systemic
CD4(+) T-cell responses induced following topical ocular or intranasal
immunization. Clin. Vaccine Immunol. 2010 Mar; 17(3):342-53.

8.

Cheng C, Bettahi I, Cruz-Fisher MI, Pal S, Jain P, Jia Z, Holmgren J,

Harandi
AM, De la Maza LM. Induction of protective immunity by
vaccination against chlamydia trachomatis using the major outer
membrane protein adjuvanted with CpG oligodeoxynucleotide
coupled to the nontoxic B subunit of cholera toxin. Vaccine. 2009 Oct;
27(44):6239-46.

9.

Bettahi I,
Dasgupta G,
Renaudet O, Yoon S,
Dumy P,
BenMohamed L.
Antitumor protective immunity induced by multivalent epitopes
glycolipopeptide candidate vaccines. Cancer Immunol Immunother.
2009 Feb; 58(2):187-200.

10. Chentoufi AA, Bender NR, Berka N, Durans G, Nguyen A, Bettahi I,

Maillere B, BenMohamed L. Asymptomatic human CD4+ cytotoxic Tcell epitopes identified from herpes simplex virus glycoprotein B. J
Virol. 2008 Dec; 82(23):11792-802.
11. Renaudet O, BenMohamed L, Dasgupta G, Bettahi I, Dumy P.
Towards a self-adjuvanting multivalent B and T cell epitope containing
synthetic glycolipopeptide cancer vaccine. ChemMedChem. 2008
May; 3(5):737-41.
12. Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen
A, Wu M, Zhu X, Mohebbi A, Buus S, Wechsler SL, Nesburn AB,
BenMohamed L. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte
epitopes identified from herpes simplex virus glycoprotein D. J
Immunol. 2008 Jan; 180(1):426-37.
13. Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V,
Vanderberg A,Wechsler SL, BenMohamed L. Protective immunity
against ocular herpes infection and disease induced by highly
immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Invest Ophthalmol Vis Sci. 2007 Oct; 48(10):4643-53.
14. Nesburn AB, Bettahi I, Dasgupta G, Chentoufi AA, Zhang X, You S,
Morishige N, Wahlert AJ, Brown DJ, Jester JV, Wechsler SL,
BenMohamed L. Functional Foxp3+ CD4+ CD25(Bright+) "natural"
regulatory T cells are abundant in rabbit conjunctiva and suppress

virus-specific CD4+ and CD8+ effector T cells during ocular herpes

infection. J. Virol. 2007 Jul; 81(14):7647-61.
15. Nesburn AB, Bettahi I, Zhang X, Zhu X, Chamberlain W, Afifi RE,
Wechsler SL, BenMohamed L. Topical/mucosal delivery of sub-unit
vaccines that stimulate the ocular mucosal immune system. Ocul
Surf.
2006
Oct;4(4):178-87.
16. Bettahi I, Zhang X, Afifi RE, BenMohamed L. Protective immunity to
genital herpes simplex virus type 1 and type 2 provided by selfadjuvanting lipopeptides that drive dentritic cell maturation and elicit a
polarized Th1 immune response. Viral Immunol. 2006 Summer;
19(2):220-236.
17. Bettahi I, Marker CL, Roman I, Wickman K. Contribution of the Kir3.1
subunit to the muscarinic-gated atrial potassium channel IKACh. J
Biol Chem. Dec; 277(50):48282-8.
18. Pozo D, Segura JJ, Jimenez-rubio A, Garcia-Perganea A, Bettahi I,
Guerrero JM, Calvo JR. Identification of G-protein coupled receptor
subunits in normal human dental pulp. J Endod. 2000 Jan; 26(1):16-9.
19. Bettahi I, Guerrero JM, Reiter RJ & Osuna C. Physiological
concentrations of melatonin inhibit the norepinephrine-induced
activation of prostaglandin E2 and cyclic AMP production in rat
hypothalamus: a mechanism involving inhibition of nitric oxide
synthase. J Pineal Res. 1998 Aug; 25(1):34-40.
20. Bettahi I, Pozo D, Osuna C, Reiter RJ, Castroviejo AD, Guerrero JM.
Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J
Pineal Res. 1996 May; 20(4):205-210.